Scaffold-free tissue-engineered arterial grafts derived from human skeletal myoblasts.
extracellular matrix
hydrostatic pressure
mechanical stress
skeletal myoblasts
tissue-engineered vascular graft
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
revised:
16
01
2021
received:
23
10
2020
accepted:
28
01
2021
pubmed:
5
2
2021
medline:
15
12
2021
entrez:
4
2
2021
Statut:
ppublish
Résumé
Tissue-engineered vascular grafts (TEVGs) are in urgent demand for both adult and pediatric patients. Although several approaches have utilized vascular smooth muscle cells (SMCs) and endothelial cells as cell sources for TEVGs, these cell sources have a limited proliferative capacity that results in an inability to reconstitute neotissues. Skeletal myoblasts are attractive cell sources as they possess high proliferative capacity, and they are already being tested in clinical trials for patients with ischemic cardiomyopathy. Our previous study demonstrated that periodic hydrostatic pressurization (PHP) promoted fibronectin fibrillogenesis in vascular SMCs, and that PHP-induced extracellular matrix (ECM) arrangements enabled the fabrication of implantable arterial grafts derived from SMCs without using a scaffold material. We assessed the molecular response of human skeletal myoblasts to PHP exposure, and aimed to fabricate arterial grafts from the myoblasts by exposure to PHP. To examine the PHP-response genes, human skeletal myoblasts were subjected to bulk RNA-sequencing after PHP exposure. Gene-set enrichment analysis revealed significant positive correlations between PHP exposure and vascular development-related genes. Real-time polymerase chain reaction (RT-PCR) demonstrated that PHP significantly upregulated collagen and elastic fiber formation-related gene expression, such as fibronectin, lysyl oxidase, collagen type I α1, collagen type IV α1, and tropoelastin. Based on these findings showing the potential role of PHP in vessel formation, we fabricated arterial grafts by repeated cell seeding and exposure to PHP every 24 hours. The resultant 15-layered myoblast grafts had high collagen content, which provided a tensile rupture strength of 899 ± 104 mm Hg. Human skeletal myoblast grafts were implanted as patch grafts in the aorta of immunosuppressed rats and found to be endothelialized and completely patent until the endpoint of 60 postoperative days. Implanted human myoblasts were gradually replaced by host-derived cells, which successfully formed vascular neotissues with layered elastic fibers. These findings suggest that human skeletal myoblasts have the potential to be a feasible cell source for scaffold-free implantable arterial grafts under PHP culture conditions.
Substances chimiques
Collagen
9007-34-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
919-932Subventions
Organisme : Japan Society for the Promotion of Science
ID : JP15H05761
Organisme : Japan Society for the Promotion of Science
ID : JP16H07107
Organisme : Japan Society for the Promotion of Science
ID : JP17K19403
Organisme : Japan Society for the Promotion of Science
ID : JP18K08767
Organisme : Japan Society for the Promotion of Science
ID : JP18K15013
Organisme : Japan Society for the Promotion of Science
ID : JP18K15681
Organisme : Japan Society for the Promotion of Science
ID : JP19H00749
Organisme : Japan Society for the Promotion of Science
ID : JP20H03650
Organisme : Japan Society for the Promotion of Science
ID : JP20K20987
Organisme : Japan Society for the Promotion of Science
ID : JP20K21638
Organisme : Miyata Cardiac Research Promotion Foundation
Organisme : Japan Agency for Medical Research and Development
ID : 19ek0109240h003
Organisme : Japan Agency for Medical Research and Development
ID : 19lm0203087h0001
Organisme : Japan Agency for Medical Research and Development
ID : 20ek0210117h0002
Informations de copyright
© 2021 International Center for Artificial Organs and Transplantation and Wiley Periodicals LLC.
Références
Hadinata IE, Hayward PA, Hare DL, Matalanis GS, Seevanayagam S, Rosalion A, et al. Choice of conduit for the right coronary system: 8-year analysis of Radial Artery Patency and Clinical Outcomes trial. Ann Thorac Surg. 2009;88:1404-9.
Kurobe H, Maxfield MW, Breuer CK, Shinoka T. Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future. Stem Cells Transl Med. 2012;1:566-71.
Matte GS. Global outreach to improve the provision of cardiopulmonary bypass for patients with congenital heart disease. Artif Organs. 2019;43:14-6.
Matsuzaki Y, John K, Shoji T, Shinoka T. The evolution of tissue engineered vascular graft technologies: from preclinical trials to advancing patient care. Appl Sci. 2019;9:1274.
Chandra P, Atala A. Engineering blood vessels and vascularized tissues: technology trends and potential clinical applications. Clin Sci. 2019;133:1115-35.
Liu X, Cai Y, Xia C, Wu H, Li Q, Xu Z, et al. An innovative method to obtain porous porcine aorta scaffolds for tissue engineering. Artif Organs. 2019;43:1162-9.
Rodrigues ICP, Pereira KD, Woigt LF, Jardini AL, Luchessi AD, Lopes ÉSN, Webster TJ, Gabriel LP. A novel technique to produce tubular scaffolds based on collagen and elastin. Artif Organs. 2020. https://doi.org/10.1111/aor.13857
Sundaram S, One J, Siewert J, Teodosescu S, Zhao L, Dimitrievska S, et al. Tissue-engineered vascular grafts created from human induced pluripotent stem cells. Stem Cells Transl Med. 2014;3:1535-43.
Luo J, Qin L, Zhao L, Gui L, Ellis MW, Huang Y, et al. Tissue-engineered vascular grafts with advanced mechanical strength from human iPSCs. Cell Stem Cell. 2020;26:251-61.e8.
Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge ASB, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003;41:879-88.
Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 2003;41:1078-83.
Sawa Y, Yoshikawa Y, Toda K, , Fukushima S, Yamazaki K, Ono M, et al. Safety and efficacy of autologous skeletal myoblast sheets (TCD-51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J. 2015;79:991-9.
Okano T, Yamada N, Okuhara M, Sakai H, Sakurai Y. Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials. 1995;16:297-303.
Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, Memon IA, et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation. 2005;80:1586-95.
Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg. 2005;130:1333-41.
Kondoh H, Sawa Y, Miyagawa S, Sakakidakitagawa S, Memon I, Kawaguchi N, et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res. 2006;69:466-75.
Hata H, Matsumiya G, Miyagawa S, Kondoh H, Kawaguchi N, Matsuura N, et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg. 2006;132:918-24.
Sekiya N, Matsumiya G, Miyagawa S, Saito A, Shimizu T, Okano T, et al. Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J Thorac Cardiovasc Surg. 2009;138:985-93.
Yokoyama U, Tonooka Y, Koretake R, Akimoto T, Gonda Y, Saito J, et al. Arterial graft with elastic layer structure grown from cells. Sci Rep. 2017;7:140.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert Bl, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50.
Davidson JM, LuValle PA, Zoia O, Quaglino D, Jr., Giro M. Ascorbate differentially regulates elastin and collagen biosynthesis in vascular smooth muscle cells and skin fibroblasts by pretranslational mechanisms. J Biol Chem. 1997;272:345-52.
Grinnell F, Fukamizu H, Pawelek P, Nakagawa S. Collagen processing, crosslinking, and fibril bundle assembly in matrix produced by fibroblasts in long-term cultures supplemented with ascorbic acid. Exp Cell Res. 1989;181:483-91.
Yoshida T, Sinha S, Dandre F, Wamhoff BR, Hoofnagle MH, Kremer BE, et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res. 2003;92:856-64.
Bachmann M, Kukkurainen S, Hytonen VP, Wehrle-Haller B. Cell adhesion by integrins. Physiol Rev. 2019;99:1655-99.
Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20:495-501.
Yanagisawa H, Wagenseil J. Elastic fibers and biomechanics of the aorta: insights from mouse studies. Matrix Biol. 2020;85-86:160-72.
L'Heureux N, McAllister TN, de la Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med. 2007;357:1451-3.
McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet. 2009;373:1440-6.
Lawson JH, Glickman MH, Ilzecki M, Jakimowicz T, Jaroszynski A, Peden EK, et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet. 2016;387:2026-34.
Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, DeRuiter MC. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg. 2005;27:566-71.
Rajab TK, O'Malley TJ, Tchantchaleishvili V. Decellularized scaffolds for tissue engineering: current status and future perspective. Artif Organs. 2020;44:1031-43.
Eyre K, Samper E, Haverich A, Hilfiker A, Andrée B. Re-endothelialization of non-detergent decellularized porcine vessels. Artif Organs. 2020. https://doi.org/10.1111/aor.13836
Yamanami M, Kanda K, Kawasaki T, Kami D, Watanabe T, Gojo S, et al. Development of xenogeneic decellularized biotubes for off-the-shelf applications. Artif Organs. 2019;43:773-9.
Krawiec JT, Weinbaum JS, Liao HT, Ramaswamy AK, Pezzone DJ, Josowitz AD, et al. In vivo functional evaluation of tissue-engineered vascular grafts fabricated using human adipose-derived stem cells from high cardiovascular risk populations. Tissue Eng Part A. 2016;22:765-75.
Nieponice A, Soletti L, Guan J, Hong Y, Gharaibeh B, Maul TM, et al. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A. 2010;16:1215-23.
Sundaram S, Echter A, Sivarapatna A, Qiu C, Niklason L. Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A. 2014;20:740-50.
Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 2005;129:1330-8.
Higgins SP, Solan AK, Niklason LE. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res A. 2003;67:295-302.
Crapo PM, Wang Y. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials. 2010;31:1626-35.
Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. J Anat. 1999;194(Pt 3):323-34.
Feng Y, Tian XY, Sun P, Cheng ZP, Shi RF. Simultaneous study of mechanical stretch-induced cell proliferation and apoptosis on C2C12 myoblasts. Cells Tissues Organs. 2018;205:189-96.
Song J, Zhang Q, Wang S, Yang F, Chen Z, Dong Q, et al. Cleavage of caspase-12 at Asp94, mediated by endoplasmic reticulum stress (ERS), contributes to stretch-induced apoptosis of myoblasts. J Cell Physiol. 2018;233:9473-87.
Shyu KG, Wang BW, Wu GJ, Lin CM, Chang H. Mechanical stretch via transforming growth factor-beta1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts. Eur J Heart Fail. 2013;15:36-45.
Hong Y, Yao Y, Wong S, Bian L, Mak AFT. Change in viability of C2C12 myoblasts under compression, shear and oxidative challenges. J Biomech. 2016;49:1305-10.
Boccafoschi F, Rajan N, Habermehl J, Mantovani D. Preparation and characterization of a scaffold for vascular tissue engineering by direct-assembling of collagen and cells in a cylindrical geometry. Macromol Biosci. 2007;7:719-26.
Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957-89.
Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, et al. Functional arteries grown in vitro. Science. 1999;284:489-93.
Mun CH, Jung Y, Kim SH, Kim HC, Kim SH. Effects of pulsatile bioreactor culture on vascular smooth muscle cells seeded on electrospun poly (lactide-co-epsilon-caprolactone) scaffold. Artif Organs. 2013;37:E168-78.
Gribova V, Liu CY, Nishiguchi A, Matsusaki M, Boudou T, Picart C, et al. Construction and myogenic differentiation of 3D myoblast tissues fabricated by fibronectin-gelatin nanofilm coating. Biochem Biophys Res Commun. 2016;474:515-21.
Baeten JT, Lilly B. Notch signaling in vascular smooth muscle cells. Adv Pharmacol. 2017;78:351-82.
Mack JJ, Iruela-Arispe ML. NOTCH regulation of the endothelial cell phenotype. Curr Opin Hematol. 2018;25:212-8.
Tetzlaff F, Fischer A. Control of blood vessel formation by notch signaling. Adv Exp Med Biol. 2018;1066:319-38.
Kitamoto T, Hanaoka K. Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. Stem Cells. 2010;28:2205-16.
Zhang Z, Chen Y, Li B, Yao Y, Jiang A, Wei W, et al. Identification of a novel miR-206-Notch3 pathway regulating mouse myoblasts proliferation. Gene. 2019;695:57-64.
Safaee H, Bakooshli MA, Davoudi S, Cheng RY, Martowirogo AJ, Li EW, et al. Tethered jagged-1 synergizes with culture substrate stiffness to modulate notch-induced myogenic progenitor differentiation. Cell Mol Bioeng. 2017;10:501-13.
L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 1998;12:47-56.
Sarkar S, Salacinski HJ, Hamilton G, Seifalian AM. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur J Vasc Endovasc Surg. 2006;31:627-36.
Steger CM, Bonatti J, Rieker RJ, Bonaros N, Schachner T. Stem cell therapy with skeletal myoblasts accelerates neointima formation in a mouse model of vein graft disease. Exp Toxicol Pathol. 2017;69:598-604.